Phase 3, Placebo Controlled, Randomized, Double-blinded, Nonsteroidal Antiinflammatory Drug add-on, Clinical Trial of NPC-01 for Treatment of Dysmenorrhea
Phase of Trial: Phase III
Latest Information Update: 04 Oct 2016
At a glance
- Drugs Ethinylestradiol/norethisterone (Primary)
- Indications Dysmenorrhoea
- Focus Therapeutic Use
- Sponsors Nobelpharma
- 04 Oct 2016 Results published in the Fertility and Sterility
- 26 Apr 2012 Actual patients number is 215 as reported by ClinicalTrials.gov.
- 26 Apr 2012 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.